167
Participants
Start Date
October 1, 2004
Primary Completion Date
October 1, 2007
Study Completion Date
March 1, 2011
NAVISTAR® THERMOCOOL® Catheter
The Biosense Webster NAVISTAR® THERMOCOOL® Diagnostic/Ablation Deflectable Tip Catheter is a luminal catheter with a deflectable tip designed to facilitate electrophysiological mapping of the heart and to transmit radiofrequency current to the catheter tip electrode for ablation purposes.
Antiarrhythmic drug
Subjects randomized to the antiarrhythmic drug (control) arm will be prescribed to a not previously administered class I or class III antiarrhythmic drug that is currently approved in the U.S. for treating atrial fibrillation.
St. Lukes Roosevelt Hospital, New York
University of Rochester Medical Center, Rochester
University of Pennsylvania, Philadelphia
Hospital San Raffaele, Milan
Johns Hopkins Hospital, Baltimore
Inova Fairfax Hospital, Falls Church
Medical University of South Carolina, Charleston
Florida Hospital, Orlando
Ohio State University Medical Center, Columbus
Riverside Methodist Hospital, Columbus
Loyola University Medical Center, Maywood
The Heart Hospital Baylor Plano Baylor Research Institute, Plano
Marin General Hospital, Greenbrae
Lahey Clinic Medical Center, Burlington
Hospital Sao Paulo, São Paulo
Montreal Heart Institute, Montreal
Na Homolce Hospital, Prague
Biosense Webster, Inc.
INDUSTRY